Literature DB >> 2677263

Diagnostic yield in CT-guided stereotactic biopsy of gliomas.

G M Greene1, P W Hitchon, R L Schelper, W Yuh, G N Dyste.   

Abstract

Twenty-seven patients underwent 29 computerized tomography (CT)-guided stereotactic biopsy procedures for untreated or recurrent malignant astrocytomas. Biopsies were obtained from the hypodense center, enhancing margin, and hypodense periphery as seen on contrast-enhanced CT scans, with diagnostic yields of (number of biopsies yielding tumor/number of biopsies obtained): 34/61 (56%), 68/101 (67%), and 8/22 (36%) from these three zones, respectively. Although tumor was identified in all three zones, diagnostic yield was significantly higher in the hypodense center and enhancing margin. Comparison of patients with untreated tumors to those with recurrent tumors demonstrated no statistical difference in tumor distribution, although there was a trend toward a higher yield from the hypodense periphery in the recurrent tumor group. Tumor was found up to 15 mm beyond the CT-enhancing margin, in addition to extending beyond the area of abnormality on T2-weighted magnetic resonance images. These findings suggest that serial stereotactic biopsies should be targeted to the hypodense center and enhancing margin for improved diagnostic yield. Biopsy material obtained from the hypodense periphery that demonstrates tumor also indicates that a tumor volume beyond the confines of the CT-enhancing margin should be considered when calculating dosimetry for interstitial radiation.

Entities:  

Mesh:

Year:  1989        PMID: 2677263     DOI: 10.3171/jns.1989.71.4.0494

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.

Authors:  Maria Protopapa; Anna Zygogianni; Georgios S Stamatakos; Christos Antypas; Christina Armpilia; Nikolaos K Uzunoglu; Vassilis Kouloulias
Journal:  J Neurooncol       Date:  2017-10-28       Impact factor: 4.130

Review 2.  Glioblastoma of the cerebellum in children: report of five cases and review of the literature.

Authors:  Gaddum D Reddy; Anish N Sen; Akash J Patel; Robert J Bollo; Andrew Jea
Journal:  Childs Nerv Syst       Date:  2013-01-09       Impact factor: 1.475

3.  Computed tomography-guided stereotactic biopsy of intracranial lesions in pediatric patients.

Authors:  Ali Meshkini; Sohrab Shahzadi; Alireza Zali; Khosro Parsa; Aimaz Afrough; Amir Hamdi
Journal:  Childs Nerv Syst       Date:  2011-07-27       Impact factor: 1.475

4.  18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.

Authors:  Robert J Harris; Timothy F Cloughesy; Whitney B Pope; Phioanh L Nghiemphu; Albert Lai; Taryar Zaw; Johannes Czernin; Michael E Phelps; Wei Chen; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

5.  Local Glioma Cells Are Associated with Vascular Dysregulation.

Authors:  S G Bowden; B J A Gill; Z K Englander; C I Horenstein; G Zanazzi; P D Chang; J Samanamud; A Lignelli; J N Bruce; P Canoll; J Grinband
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

6.  Glioma after cerebral hydatid disease.

Authors:  E J St George; C E M Hillier; R Hatfield
Journal:  Childs Nerv Syst       Date:  2003-10-18       Impact factor: 1.475

7.  Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system.

Authors:  H C Wang; Y S Ho
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

Review 8.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

9.  Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model.

Authors:  Gavin W Britz; Saadi Ghatan; Alexander M Spence; Mitchel S Berger
Journal:  J Neurooncol       Date:  2002-02       Impact factor: 4.130

Review 10.  Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.

Authors:  Edward Rustamzadeh; Chunbin Li; Sekou Doumbia; Walter A Hall; Daniel A Vallera
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.